Search results

Collaborations 1

• Wyss AI DataHub
  The Wyss Institute’s AI DataHub integrates patient samples, cutting-edge tissue models, and multi-omics technologies to generate rich, translational datasets – accelerating breakthroughs in drug discovery, biomarker development, and beyond through strategic partnerships.

News 6

View all

• Community
  
  Sanjid Shahriar on Using Computational Biology to Cross the Blood-Brain Barrier
  July 1, 2025
• Community
  
  Translational AI at the Wyss Institute: how artificial intelligence enables patient impact
  June 26, 2025
• Community
  
  Beyond Animals: Revolutionizing Drug Discovery with Human-Relevant Models
  April 2, 2025

Multimedia 2

• 

  Video/Animation
  Atlantic Health: Accelerating Innovation – AI and Drug Discovery
  The Atlantic’s Health Summit returned to Boston in 2025 for their annual exploration of the urgent issues reshaping the healthcare landscape. The event showcased recent breakthroughs that are redefining medical practices and explored the challenges of scaling innovation and implementing sustainable solutions. Speakers explored early disease detection, novel anesthetics, pain management, AI and drug discovery,...

• 

  Audio/Podcast
  SeqVerify: A New Easily Accessible Tool for Comprehensive Cell Line Quality Assessment – The Stem Cell Report
  During the last decade, advances in genome editing and pluripotent stem cell (PSC) culture have let researchers generate edited PSC lines to study a wide variety of biological questions. However, abnormalities in cell lines such as aneuploidy, mutations, on-target and off-target editing errors, and microbial contamination can arise during PSC culture or due to undesired...